Bird & Bird strengthens its Life Sciences Group with the appointment of Liz Fuller as partner


Bird & Bird appoints Liz Fuller as partner in the International Life Sciences Group to be based in the London office until spring 2011, when she will move permanently to our Lyon office.  Liz joins from Wragge & Co in London and is a practising US lawyer for over twenty years, focusing on regulatory and corporate life sciences work.

Liz’s practice is focused on the development and regulation of pharmaceutical and biotechnology products, working with clients in the EU and US throughout the pharmaceutical life cycle.  Her thorough knowledge of the strategic concerns and legal issues affecting pharmaceutical development makes Liz highly sought-after across the industry.   In addition to her regulatory expertise, Liz has extensive experience with technology licensing, contract drafting and negotiation, both in biotechnology and other pharmaceutical contexts.

Commenting on Liz’s appointment, Trevor Cook, Joint-Head of the International Life Sciences Group, said: “We are delighted to welcome Liz to the team as her expertise is an ideal fit to build our position across Lyon, Grenoble and Geneva which form a central hub for the Life Sciences industry in Europe.  Liz will be a great complement to our team’s thorough understanding of the strategic and commercial issues affecting the pharmaceutical and biotech industry.

We are about to enter into unprecedented change in the pharmaceutical industry – as the pipeline of blockbuster drugs runs dry and generic manufacturers shift their strategies away from cost competition.  The combination of patent expirations and the introduction of ‘biosimilar’ products will create a dynamic battleground in Europe, which has no equivalent yet in the US.  Negotiating this battleground, both in Europe and in the jurisdictions that will be following this lead, will require strong and integrated patent and regulatory practices for which we are ideally-positioned to help our clients.”